935106861
info@markelab.com
Precio
250€ (80 µl)
AKT2 is a putative oncogenic protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. Furthermore, AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression of AKT2 contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. AKT2 is a general protein kinase capable of phophorylating several known proteins.
Primary Antibodies
Polyclonal
Human, Mouse
RAC-Beta Serine/threonine-Protein Kinase (AKT2)
Rabbit
Unconjugated
Liquid
ELISA, WB, IF/ICC, FCM
Purified through a protein A column, followed by peptide affinity purification.
PBS containing 0.09% sodium azide.
80 µl
400 µl
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
AKT2
No
Shipped within 5-10 working days.
AKT2,PKB beta,Protein kinase Akt ,Protein kinase B beta
This product is for research use only.
Precio a consultar
Ver másAKT2 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which...
Precio a consultar
Ver másPrecio a consultar
Ver más